Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
$1.01M Buy
35,758
+3,641
+11% +$104K 0.6% 62
2014
Q1
$978K Sell
32,117
-2,258
-7% -$67.3K 0.63% 62
2013
Q4
$999K Sell
34,375
-664
-2% -$19.3K 0.62% 65
2013
Q3
$955K Sell
35,039
-3,737
-10% -$102K 0.67% 63
2013
Q2
$1.03M Buy
+38,776
New +$1.07M 0.77% 52

Other funds holding PFE

Bankers Trust's PFE Position: Q2 2014 in Review

Bankers Trust increased its Pfizer (PFE) stake by 11% in Q2 2014, buying an estimated $104K and bringing the position to 35,758 shares worth $1.01M. The position accounts for 0.6% of the portfolio, ranked #62.

Bankers Trust first reported a position in PFE in Q2 2013 and has held it in 5 quarters since. The position peaked at $1.03M in Q2 2013. 1,747 funds tracked by Wall St. Rank hold PFE as of Q2 2014.

  • Bankers Trust held 35,758 shares of Pfizer worth $1.01M as of Q2 2014.
  • Bankers Trust bought 3,641 Pfizer shares in Q2 2014, an estimated $104K.
  • Pfizer made up 0.6% of Bankers Trust's portfolio in Q2 2014, its #62 holding.
  • Bankers Trust first reported a position in Pfizer in Q2 2013 and has held it in 5 quarters since.
  • Bankers Trust's Pfizer position peaked at $1.03M in Q2 2013.
  • 1,747 funds tracked by Wall St. Rank held Pfizer as of Q2 2014.

Based on Bankers Trust's 13F filing for Q2 2014, filed 15 Aug 2014.